MRNA Jul 2024 147.000 put

OPR - OPR Delayed price. Currency in USD

Add to watchlist

12.90

0.00

(0.00%)

As of 10:48AM EDT. Market open.

Loading interactive chart…

Zacks
CDC Narrows Age Recommendation for Use of RSV Vaccine
The U.S. CDC recommends that adults aged 75 years and above get an RSV shot. Those aged 60 to 74 years should only get the shot if they are at high risk for severe RSV due to chronic conditions.
Zacks
Pfizer (PFE), BioNTech's Updated COVID-19 Jab Gets CHMP Nod
Pfizer (PFE) and BioNTech's Omicron JN.1-adapted COVID-19 vaccine gets the Committee for Medicinal Products for Human Use's positive opinion recommending marketing authorization.
Zacks
Moderna (MRNA) Shares Decline on RSV Vaccine Efficacy Data
Moderna (MRNA) stock sinks after new data shows the efficacy of its mRNA-based RSV vaccine fell sharply in the second year and was lower than that of rival vaccines marketed by GSK and Pfizer.